Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.

Source:http://linkedlifedata.com/resource/pubmed/id/16420092

Download in:

View as

General Info

PMID
16420092